You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 14 Next »


Project Scope

This project is to evolve the Nonclinical Study Data Reviewer's Guide (nSDRG), based on comments from a public PHUSE review, plus to adapt it to updates of the FDA Technical Conformance Guide. The project continues to check and align with the SDRG template and guide developed by the Optimizing the Use of Data Standards Working Group for clinical studies.

Preparation of a Study Data Reviewer’s Guide (SDRG) is recommended as an integral part of a CDISC standards-compliant study data submission. The challenge is to operationalise this new documentation requirement efficiently and effectively.
Challenges we seek to answer with this project:

  • Provide a practical template for easy access and use

  • Provide guidance document which describes expected content and options to guide nonclinical SDRG authors.

  • Provide authors with examples, describing how to handle different data situations with SDRG content.

Things we expect to learn along the way:

  • Exploration of ways to generate the nonclinical SDRG and who should do the job.

  • The SDRG is expected to be useful by FDA reviewers. Can it also be useful for other nonclinical study stakeholders?

  • Will the SDRG evolve as systems and processes gain expertise in the new SEND requirements for submission of nonclinical data?

Project Leads

Email

Debra Oetzman

debra.oetzman@instem.com

Sue Dehaven

susan.dehaven@sanofi.com

Lauren White (PHUSE Project Coordinator)lauren@phuse.eu



Key Milestones 

ObjectiveTimeline
Maintain the Nonclinical SDRG based on FDA's TCG and any public feedback Q4 2020 


CURRENT STATUS

Completed updates of sections 1-4 of the Reviewer's Guide Completion Guideline. Expected to publish the updated version of the nSDRG template and guide for public review by end of Q4 2020. 


The Nonclinical SDRG package has been developed to comply with the FDA's Study Data Technical Conformance Guide. The current version of this document can be found at the website: FDA Data Standards Resources. The nSDRG team continues to monitor FDA's Technical Conformance Guide updates (which occur 2X per year, expected in MAR and OCT) and also public comments received from users of nSDRG. As these new inputs are evaluated, we will post answers in the SEND Implementation Forum, and update the published documents as needed. Stay tuned for update announcements.

Project Members 

Organisation 
Anja MetzgerBayer

Brett Coupland

Astrazeneca

Cathy Roy

Merck

Christy Kubin 

MPI Research

Daniel Potenta 

PDS Lifesciences

Debra Oetzman

Instem

Deepika V.G 

Point Cross
Florence Halbert Novartis
Gitte Frausing Data Standards Decisions
Hepei Chen FDA
Jack Baker Covance
Jennifer Abbott Abbvie
Jennifer Feldmann Epreda
Karen Porter Point Cross
Kenneth Hershman Novartis

Project Members 

Organisation 

Linda Hunt 

Merck

Lindsy Eickhoff 

Basinc

Mandie Rhodes 

BMS

Mark Carfagna 

Eli Lilly
Matthew WhittakerFDA
Maureen Rossi Roche
Michael Rosentreter Bayer
Nicola Robertson GSK
Patricia Brundage FDA
Paul Brown FDA
Rick Thompson J&J
Senthil Palani Xybion
Steve PolleyGSK
Susie Lendal Antvorskov Data Standards Decisions
Tania Smith Covance
William Houser BMS
  • No labels